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Introduction
The development of multidrug resistance (MDR) 
to chemotherapy remains a major challenge in the 
treatment of cancer (Ullah, 2008; Ren et al., 2012; Zhu 
et al., 2013). Resistance exists against every effective 
anticancer drug and can develop by numerous mechanisms 
including decreased drug uptake, increased drug efflux, 
activation of detoxifying systems, activation of DNA 
repair mechanisms, evasion of drug-induced apoptosis, 
etc.(Sonneveld, 2000; Wu et al., 2014). One of the major 
mechanisms for drug resistance is associated with altered 
anticancer drug transport, mediated by members of the 
ABC transporter superfamily proteins including ABCB1 
gene (Golalipour et al., 2007; Oliveira et al., 2014). 
ABCB1, the first discovered ABC transporter, is 
expressed in various tissues to protect them from the 
adverse effect of toxins (Fung and Gottesman, 2009). 
The properties ABCB1 expression have been extensively 
studied in cancer (Juliano and Ling, 1976; Wallner et 
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Abstract
 Background: One of the major mechanisms for drug resistance is associated with altered anticancer drug 
transport, mediated by the human-adenosine triphosphate binding cassette (ABC) transporter superfamily 
proteins. The overexpression of adenosine triphosphate binding cassette, sub-family B, member 1 (ABCB1) 
by multidrug-resistant cancer cells is a serious impediment to chemotherapy. In our study we have studied the 
possibility that structural single-nucleotide polymorphisms (SNP) are the mechanism of ABCB1 overexpression. 
Materials and Methods: A total of 101 gastric cancer multidrug resistant cases and 100 controls were genotyped 
with sequence-specific primed PCR (SSP-PCR). Gene expression was evaluated for 70 multidrug resistant cases 
and 54 controls by real time PCR. The correlation between the two groups was based on secondary structures 
of RNA predicted by bioinformatics tool. Results: The results of genotyping showed that among 3 studied SNPs, 
rs28381943 and rs2032586 had significant differences between patient and control groups but there were no 
differences in the two groups for C3435T. The results of real time PCR showed over-expression of ABCB1 when 
we compared our data with each of the genotypes in average mode. Prediction of secondary structures in the 
existence of 2 related SNPs (rs28381943 and rs2032586) showed that the amount of ∆G for original mRNA is 
higher than the amount of ∆G for the two mentioned SNPs. Conclusions: We have observed that 2 of our studied 
SNPs (rs283821943 and rs2032586) may elevate the expression of ABCB1 gene, through increase in mRNA 
stability, while this was not the case for C3435T. 
Keywords: Gastric cancer - variation - ABCB1 gene - real time PCR - multidrug resistance (MDR) - over-expression
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al., 1993; Sonneveld, 2000; Felipe et al., 2014). Patients 
with high expression of ABCB1 at diagnosis may be 
predisposed to mutation development. Furthermore, 
increasing expression of ABCB1 over time may be 
contributing to acquiring drug resistance. ABCB1 
activation may be an important prognostic marker, 
and potential target for pharmacological manipulation 
(Deborah et al., 2006). Different mechanisms proposed for 
ABCB1 over-expression including Mutation, Aneuploidy 
(rearrangements and gene amplification) and SNPs 
(including SNPs in promoter and structural SNPs in RNA) 
(Baker and El-Osta, 2003; Wang et al., 2006; Mahjoubi et 
al., 2008; Fung and Gottesman, 2009; Wang et al., 2009). 
Gene amplification is also described in some cellular 
models but it seems to be uncommon in clinical species 
(Roninson et al., 1991; Golalipour et al., 2007).
In the present study we have investigated the possible 
role of structural SNP in the over-expression of the ABCB1 
gene. There is only one report of applying SNPs with the 
structural view for the ABCB1 gene that potentially have 
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an effect on performance (Fung and Gottesman, 2009). 
As a result of the paucity of SNP polymorphism in the 
processing locations in literature, we have assessed SNPs 
polymorphism in splicing site, including rs28381943 and 
rs2032586. We also included C3435T, located in exon 
26, which is commonly used in different studies and has 
shown different frequencies of polymorphisms that vary 
significantly in different ethnicities (Gow et al., 2008; 
Andersen et al., 2009; Fung and Gottesman, 2009).
Materials and Methods
Samples
Seventy fresh peripheral blood samples were collected 
from patients with gastric cancers (including esophageal, 
colon, stomach and rectum) treated with 5FU and as a 
control 100 blood samples were collected from healthy 
controls that did not have a history of cancers (10 ml from 
each person which, collected in falcon tubes that contained 
EDTA). In addition 31 tissue samples were collected 
from paraffin embedded tissue blocks of patients with the 
mentioned cancers (gastric cancers).
DNA and RNA extraction.
DNA is extracted using the phenol-chloroform method. 
The PMBC (Peripheral blood mononuclear cell) was 
separated using ficole. The PMBC was then cultured 
in an RPMI-1640 medium and cells were stimulated 
to divide with PMA and LPS. After 72 hours RNA was 
extracted from cultured cells by TRIZOL based method. 
The isolated RNA was used to synthesize cDNA using 
Fermentase kit of first strand cDNA synthesis.
Genotyping
Genotyping was done with SSP-PCR (Sequence 
Specific Primer) for 101 cancer cases and the 100 control 
group. Primers for SSP-PCR were designed with primer3 
software (Table 1). Human Growth Hormone (HGH) 
primers were used as a control to check the results of 
SSP-PCR.
ABCB1 mRNA quantification
The amount of gene expression was measured 
using Relative Quantitative Real Time PCR (ABI 
7300) for all 101 cancer cases and 100 controls. These 
primers were used for Real Time PCR: Forward: 5’ 
GAGCCCATCCTGTTGACTG 3’ and Reverse: 5’ 
ACTATAGGCCAGAGAGGCTGC 3’(Song et al., 2002). 
18srRNA was used as an internal control.
RNA structure prediction and statistical analysis
To check the effect of our SNPs on mRNA structure, 
the Vienna RNA fold web servers (http://rna.tbi.univie.
ac.at/) were used to predict the secondary structures of 
RNA and its folding based on MFE (Minimum Free 
Energy). This database predicted the amount of ∆G for 
the requested sequences with the knowledge that there is 
an inverse correlation between the ∆G and the stability 
of the molecules. Statistical calculations and tests were 
performed using the SPSS 16.0 software (SPSS, Inc., 
Chicago, IL). Normality of data was tested using the 
Shapiro-Wilk normality test. Differences between groups 
were analyzed by one-way ANOVA and the limit of 
statistical significance was defined as p<0.05.
Results 
rs28381943 and rs2032586 genotypic frequencies
A total number of 201 cases were classified in two 
different groups; Cancer patients cases (N=101), and 
healthy control individuals with no history of cancer 
(N=100). ABCB1 polymorphism at positions rs28381943, 
rs2032586 and C3435T were determined and the 
distribution of genotypes in cancer cases and healthy 
controls were compared. Also the genotyping analysis was 
done for tissue samples to support and increase the sample 
size for polymorphism determination. These results are 
presented in Tables 2-7.
The results of genotyping showed that there is a 
significant difference in both genotypic and allelic 
frequencies for rs28381943 SNP between the cancer 
subjects and the control group. For rs2032586 there is 
no significant difference in allelic frequencies while 
there existed a significant difference in the genotypic 
frequencies between two groups.
 For the C3435T position we have not seen any 
differences between the cancer subjects and the control 
group either in the allelic or genotypic frequencies. The 
cancer subjects showed significant genotypic frequency 
differences for both A/G and G/G genotypes for 
rs2032586. Also, for rs28381943 a significant difference 
in the G/G genotype is presented. The differences which 
were observed in genotypes between tumoral and normal 
tissue samples of a person may be because of lack of 
control on DNA replication or mutations which occurs in 
tumoral development.
mRNA level increased in mutated genotype 
The results of Real Time PCR showed an over-
expression of ABCB1 when we compared our data with 
each genotypes in average mode. The results of the 
evaluation of ABCB1 expression are presented in Chart 
1 and Chart 2.
Mutated mRNA have lower ∆G compared to original 
mRNA
0
25.0
50.0
75.0
100.0
N
ew
ly
 d
ia
gn
os
ed
 w
ith
ou
t 
tr
ea
tm
en
t 
N
ew
ly
 d
ia
gn
os
ed
 w
ith
 t
re
at
m
en
t 
Pe
rs
is
te
nc
e 
or
 r
ec
ur
re
nc
e
Re
m
is
si
on
N
on
e
Ch
em
ot
he
ra
py
Ra
di
ot
he
ra
py
Co
nc
ur
re
nt
 c
he
m
or
ad
ia
tio
n
10.3
0
12.8
30.025.0
20.310.16.3
51.7
75.0
51.1
30.031.3
54.2
46.856.3
27.625.0
33.130.031.3
23.7
38.0
31.3
Table 1. Primer Sequences used for the ABCB1 Gene 
in Positions C3435T, rs28381943 and rs2032586 for 
Sequence-Specific Primer Genotyping Method
Primer Sequence  Primer Position
5’ GTGGTGTCACAGGAAGAGGTT 3’ C3435T T
5’ GTGGTGTCACAGGAAGAGGTC 3’ C3435T C
5’ ACTAATAGGCCAGAGAGGCTGC 3’ Generic 
5’ CGATCCATGCTCAGACAGGTA 3’ rs28381943 A
5’ CGATCCATGCTCAGACAGGTG 3’ rs28381943 G
5’ TTCAACCGCATCTCTGACGT 3’ Generic
5’ GTTCAGACCCTTCAAGATCTACA 3’ rs2032586 A
5’ TTCAGACCCTTCAAGATCTACG 3’ rs2032586 G
5’ ACTTCAGTTACCCATCTCGAA 3’ Generic 
5-GCCTTCCCAACCATTCCCTTA-3 HGH (sense)
5-TCACGGATTTCTGTTGTGTTTC-3 HGH (antisense)
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ABCB1 mRNA structure ∆G is -1586.68 kcal/mol. 
The amount of ∆G in rs28381943 is -2482.30 kcal/mol. 
rs28381943 may cause disruption in the splicing process, 
resulting in the observation of intron 19 that is usually 
deleted through normal splicing. Also rs2032586 may 
cause disruption in the splicing process, resulting in the 
inclusion of intron 11 that is usually deleted through 
normal splicing. The amount of ∆G is -1634.12kcal/mol. 
Table 4. The Genotypic and Allelic Frequency Distribution for C3435T in ABCB1 Gene in Blood Samples
Genotype Subjects (%) Control (%) P OR 95 CI %
C/C 23(63.9%) 13(36.1%) 1 - -
C/T 56(44.8%) 69(55.2%) 0.475 0.738 0.344-1.58
T/T 22(52.4%) 20(47.6%) 0.3618 1.608 0.59-4.43
Allele”C” 102(50.50%) 95(46.57%) 1 - -
Allele”T” 100(49.5%) 109(53.43%) 0.487 1.17 0.778-1.76
OR= odds ratio. CI= 95% Confidence Interval of the odds ratio. P= p-value
Table 3. The Genotypic and Allelic Frequency Distribution for rs2032586 in ABCB1 Gene in Blood Samples
Genotype Subjects (%) Control (%) P OR 95 CI %
A/A 61(53%) 54(47%) 1 - -
A/G 22(31%) 49(69%) 0.001 11.878 0.015-0.346
G/G 16(84.2%) 3(15.8%) 0.01 4.721 0.038-0.806
Allele”A” 144(72.73%) 157(74.06%) 1 - -
Allele”G” 54(27.27%) 55(25.94%) 0.82 0.934 0.588-1.484
OR= odds ratio. CI= 95% Confidence Interval of the odds ratio. P= p-value
Table 5. The Genotypic and Allelic Frequency Distribution for C3435T in ABCB1 Gene in Blood Samples
Genotype Subjects (%) Control (%) P OR 95 CI %
C/C 4(12.9%) 5(15.6%) 1 - -
C/T 19(61.3%) 19(59.4%) 0.5288 0.8 0. 137-4.393
T/T 8(25.8%) 8(25.0%) 0.6168 1 0. 264-3.782
Allele”C” 27(43.55%) 29(45.31%) 1 - -
Allele”T” 35(56.45%) 35(54.69%) 0.492 0.931 0. 434-1.995
OR= odds ratio. CI= 95% Confidence Interval of the odds ratio. P= p-value
Table 2. The Genotypic and Allelic Frequency Distribution for rs28381943 in ABCB1 Gene in Blood Samples
Genotype Subjects (%) Control (%) P OR 95 CI %
A/A 35(42.7%) 47(57.3%) 1 - -
A/G 46(49.5%) 47(50.5%) 0.014 3.4057 0.089-0.854
G/G 20(76.9%) 6(23.1%) 0.003 4.476 0.067-0.662
Allele”A” 116(57.42%) 141(70.5%) 1 - -
Allele”G” 86(42.57%) 59(29.5%) 0.007 1.7717 0.365-0.870
OR= odds ratio. CI= 95% Confidence Interval of the odds ratio. P= p-value
Table 7. The Genotypic and Allelic Frequency Distribution for rs28381943 in ABCB1 Gene in Blood Samples
Genotype Subjects (%) Control (%) P OR 95 CI %
AA/A 11(35.5%) 11(34.4%) 1 - -
A/G 14(45.2%) 11(34.4%) 0.4528 0. 785 0. 213-2.882
G/G 6(19.4%) 10(31.2%) 0.202 2.121 0. 496-9.410
Allele”A” 36(58.06%) 33(51.56%) 1 - -
Allele”G” 26(41.94%) 31(48.44%) 0.289 1.3 0.607-2.791
OR= odds ratio. CI= 95% Confidence Interval of the odds ratio. P= p-value
Table 6. The Genotypic and Allelic Frequency Distribution for rs2032586 in ABCB1 Gene in Blood Samples
Genotype Subjects (%) Control (%) P OR 95 CI %
A/A 4(13.8%) 5(16.7%) 1 - -
A/G 15(51.7%) 18(60.0%) 0.6286 0.96 0. 159-5.395
G/G 10(34.5%) 7(23.3%) 0.2756 0.583 0.149-2.216
Allele”A” 23(39.65%) 28(46.66%) 1 - -
Allele”G” 35(60.35%) 32(53.34%) 0.28 0. 751 0. 338-1.660
OR= odds ratio. CI= 95% Confidence Interval of the odds ratio. P= p-value
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Discussion
Our data suggests that rs283821943 and rs2032586 
SNPs may be the reason for the over-expression of the 
ABCB1 gene because of the significant differences which 
were observed among genotypes. Our results showed that 
GG allele has higher mRNA level compared to AA allele. 
The expression of the ABCB1 gene in the existence of 
these SNPs is higher than normal. On the other hand, we 
have shown that the existence of these SNPs may lead to 
the stabilization of ABCB1 mRNA causing the ABCB1 
gene to become overexpressed. The amount of ∆G for 
ABCB1 mRNA is -1586.68 kcal/mol which is lower 
than -2482.30 kcal/mol for ABCB1 mRNA in the case 
of rs28381943 SNP existence and also -1634.12kcal/
mol for ABCB1 mRNA in the case of rs2032586 SNP 
existence. As previous studies represent (Wu et al., 2014), 
C3435T position has not shown any differences between 
case and control group neither in allelic frequencies nor 
in genotypic frequencies. Our data suggest that SNPs in 
splicing position may be a place of more experiments to 
reveal if they may be the reason for mRNA stabilization 
leading to gene overexpression.
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